MW Encap Limited
Registered name: MW ENCAP LIMITED
Part of Nextpharma Technologies Limited groupMW Encap Limited made £12.8m revenue and £2.8m profit in the year to 31 Dec 2025.
MW Encap Limited’s revenue grew 14% to £12.8m in the year to 31 Dec 2025, with £2.8m profit and 96 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in London; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- London, London
- Age
- 32 yrs · since 1994
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £13.5m | £11.2m | £12.8m |
| Cost of sales | £11m | £10m | £8.5m |
| Gross profit | £2.5m | £1.2m | £4.2m |
| Operating profit | −£655k | −£827k | £2.3m |
| Profit before tax | −£124k | −£209k | £2.6m |
| Profit after tax | −£256k | −£286k | £2.8m |
| Profit (best available) | −£256k | −£286k | £2.8m |
| Staff costs | £5.2m | £5.3m | £5.2m |
| Employees (average) | 122 | 114 | 96 |
| Ratios | |||
| Profit margin | −1.9% | −2.5% | 21.6% |
| Gross margin | 18.4% | 10.9% | 33% |
| Revenue per employee | £111k | £98.3k | £133k |
| Profit per employee | −£2.1k | −£2.5k | £28.7k |
| Growth (year on year) | |||
| Revenue growth | — | ▼17% | ▲13.9% |
| Headcount growth | — | ▼6.6% | ▼15.8% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £1.2m | £1.1m | £2.6m |
| Net assets | £19.7m | £19.5m | £21.9m |
| Fixed assets | £7.2m | £6.4m | £10m |
| Current assets | £16m | £17.5m | £21.9m |
| Debtors | £3.3m | £2.3m | £2.8m |
| Deferred income | £747k | £1.4m | £1.1m |
| Source | FullAccounts · bulk data Sep 2025 | FullAccounts · bulk data Sep 2025 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- 21.6%
- Profit ÷ revenue.
- Gross margin
- 33%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £133k
- Revenue ÷ average employees.
- Profit per employee
- £28.7k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 78%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 9%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 22.1%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲13%
- Now £21.9m
- Cash at bank
- ▲147%
- Now £2.6m
- Headcount
- ▼16%
- Now 96
- Deferred income
- ▼19%
- Now £1.1m
- Fixed assets
- ▲56%
- Now £10m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Nextpharma Technologies Limitedultimate parent75–100%
- MW Encap (Holdings) Limited75–100%
- MW Encap Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Manx Healthcare LimitedWarwick · Manufacture of basic pharmaceutical products
- Revenue
- £12.6m
- Profit
- £5.6m
- Staff
- 31
- Fontus Health LtdWalsall · Manufacture of basic pharmaceutical products
- Revenue
- £13.4m
- Profit
- £2m
- Staff
- 20
- Envigo RMS (UK) LimitedLoughborough · Manufacture of basic pharmaceutical products
- Revenue
- £11.4m
- Profit
- £209k
- Staff
- 145
- Cosmarida LimitedSheffield · Manufacture of basic pharmaceutical products
- Revenue
- £11.1m
- Profit
- £286k
- Staff
- 90
- Pharmapac (U.K.) LimitedBidston, Wirral · Manufacture of basic pharmaceutical products
- Revenue
- £10.8m
- Profit
- £94.7k
- Staff
- 142
- Vector Consumer LimitedPrenton · Manufacture of basic pharmaceutical products
- Revenue
- £10.6m
- Profit
- £33.1k
- Staff
- 14
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £2.8m), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.